A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians

OBJECTIVE Early detection of type 1 diabetes through islet autoantibody (IAb) testing can improve disease trajectory and reduce complications. To optimize efforts to improve IAb screening, research is needed to better understand the facilitators and barriers to screening among U.S. physicians. RESEARCH DESIGN AND METHODS This mixed-methods study, which used the Theoretical Domains Framework from implementation science, was designed to identify key barriers and facilitators to IAb screening among U.S. physicians, prioritize those barriers and facilitators to identify where efforts to support practice change are most needed, and link those barriers and facilitators to behavioral change techniques (BCTs) to improve screening behaviors. The qualitative phase included interviews with family medicine physicians (n = 15) and pediatricians (n = 15). The quantitative phase used maximum difference scaling to rank physicians’ (n = 200) facilitators and barriers and regression modeling to assess whether priority barriers and facilitators predict screening behavior. RESULTS Twelve key barriers and facilitators emerged (e.g., lacking awareness of presymptomatic IAb testing, believing presymptomatic testing would have negative impacts on patients). BCTs associated with these included feedback, persuasive communication, and self-monitoring. Family physicians prioritized knowledge gaps as a key barrier (e.g., not understanding the application of IAb testing in detecting presymptomatic type 1 diabetes), whereas pediatricians prioritized motivational barriers (e.g., IAb testing not being a high clinical priority). CONCLUSIONS Findings reveal new insights into U.S. physician screening behaviors for presymptomatic type 1 diabetes. These results could inform the development and implementation of targeted, actionable communication strategies and other interventions to support routine IAb testing.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Cardiometabolic CARE
Published
2026-11-16
DOI
https://doi.org/10.2337/doc26-0089
Primary Topic
Health Policy Implementation Science
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians

Jay H. Shubrook, Richard J. Spiegel, Shpetim Karandrea, Tom Bregartner et al.
5 links
Diabetes Obesity and Cardiometabolic CARE
Health Policy Implementation Science
article

A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians

Jay H. Shubrook, Richard J. Spiegel, Shpetim Karandrea, Tom Bregartner, Marissa Mays-Verman, Lauren Welch, Daniel Rojas, Eric Du
article en

Abstract

OBJECTIVE Early detection of type 1 diabetes through islet autoantibody (IAb) testing can improve disease trajectory and reduce complications. To optimize efforts to improve IAb screening, research is needed to better understand the facilitators and barriers to screening among U.S. physicians. RESEARCH DESIGN AND METHODS This mixed-methods study, which used the Theoretical Domains Framework from implementation science, was designed to identify key barriers and facilitators to IAb screening among U.S. physicians, prioritize those barriers and facilitators to identify where efforts to support practice change are most needed, and link those barriers and facilitators to behavioral change techniques (BCTs) to improve screening behaviors. The qualitative phase included interviews with family medicine physicians (n = 15) and pediatricians (n = 15). The quantitative phase used maximum difference scaling to rank physicians’ (n = 200) facilitators and barriers and regression modeling to assess whether priority barriers and facilitators predict screening behavior. RESULTS Twelve key barriers and facilitators emerged (e.g., lacking awareness of presymptomatic IAb testing, believing presymptomatic testing would have negative impacts on patients). BCTs associated with these included feedback, persuasive communication, and self-monitoring. Family physicians prioritized knowledge gaps as a key barrier (e.g., not understanding the application of IAb testing in detecting presymptomatic type 1 diabetes), whereas pediatricians prioritized motivational barriers (e.g., IAb testing not being a high clinical priority). CONCLUSIONS Findings reveal new insights into U.S. physician screening behaviors for presymptomatic type 1 diabetes. These results could inform the development and implementation of targeted, actionable communication strategies and other interventions to support routine IAb testing.

Diabetes Obesity and Cardiometabolic CARE
Touro University California (US)
Sanofi
Good health and well-being
Health Policy Implementation Science
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon